liu.seSearch for publications in DiVA
Change search
ReferencesLink to record
Permanent link

Direct link
Current state of adjuvant therapy in resected pancreatic adenocarcinoma
Herlev Hospital, University of Copenhagen, Herlev, Denmark.
Karolinska University Hospital, Stockholm, Sweden.
2006 (English)In: Acta Oncologica, ISSN 0284-186X, E-ISSN 1651-226X, Vol. 45, no 2, 124-135 p.Article, review/survey (Refereed) Published
Abstract [en]

Pancreatic carcinoma cannot generally be cured by surgery alone. This review summarizes the development of adjuvant therapy over the past two decades. Four randomized controlled trials compare long-term survival of different treatments. The small GITSG-study supports combined chemoradiation, but the EORTC-study found no significant effect. A Norwegian study of adjuvant chemotherapy found an increased median survival, but no effect beyond two years. The large ESPAC-1 study shows a benefit for 5-FU based chemotherapy, while chemoradiation had a negative effect. Thus, evidence favours adjuvant therapy, but 5-FU may not be the ultimate drug. Support for gemcitabine is given by preliminary data from a German randomized trial, and further American and European studies are upcoming. However, postoperative therapy is problematic, as 20-30% of resected patients never undergo treatment because of slow recovery or other reasons. Preoperative therapy has some theoretical advantages, and moreover, patients with rapidly progressive disease may be spared surgery. Randomized controlled trials are lacking, but published results compare well with postoperative, adjuvant therapy. The value of locally targeted therapy is difficult to assess. Reasonable results have been obtained with regional chemotherapy, whereas intraoperative radiotherapy does not seem to increase survival despite reducing reducing local recurrences.

Place, publisher, year, edition, pages
Informa Healthcare, 2006. Vol. 45, no 2, 124-135 p.
National Category
Medical and Health Sciences
URN: urn:nbn:se:liu:diva-101361DOI: 10.1080/02841860600554238PubMedID: 16546857OAI: diva2:666093
Available from: 2013-11-21 Created: 2013-11-21 Last updated: 2013-12-05Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Albertsson, Maria
In the same journal
Acta Oncologica
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 16 hits
ReferencesLink to record
Permanent link

Direct link